nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—NTRK1—glaucoma	0.151	0.451	CbGaD
Imatinib—CA1—glaucoma	0.104	0.312	CbGaD
Imatinib—CA2—glaucoma	0.0792	0.237	CbGaD
Imatinib—CA3—Acetazolamide—glaucoma	0.0276	0.0579	CbGbCtD
Imatinib—CA14—Brinzolamide—glaucoma	0.0167	0.0349	CbGbCtD
Imatinib—CA14—Diclofenamide—glaucoma	0.0167	0.0349	CbGbCtD
Imatinib—CA14—Dorzolamide—glaucoma	0.0161	0.0337	CbGbCtD
Imatinib—CA6—Brinzolamide—glaucoma	0.0158	0.0332	CbGbCtD
Imatinib—CA6—Diclofenamide—glaucoma	0.0158	0.0332	CbGbCtD
Imatinib—CA6—Dorzolamide—glaucoma	0.0153	0.032	CbGbCtD
Imatinib—CA14—Methazolamide—glaucoma	0.0144	0.0301	CbGbCtD
Imatinib—CA7—Brinzolamide—glaucoma	0.0138	0.0289	CbGbCtD
Imatinib—CA7—Diclofenamide—glaucoma	0.0138	0.0289	CbGbCtD
Imatinib—CA6—Methazolamide—glaucoma	0.0136	0.0285	CbGbCtD
Imatinib—CA7—Dorzolamide—glaucoma	0.0133	0.0279	CbGbCtD
Imatinib—CA7—Methazolamide—glaucoma	0.0119	0.0249	CbGbCtD
Imatinib—CA9—Diclofenamide—glaucoma	0.0118	0.0248	CbGbCtD
Imatinib—CA12—Diclofenamide—glaucoma	0.0118	0.0248	CbGbCtD
Imatinib—CA9—Brinzolamide—glaucoma	0.0118	0.0248	CbGbCtD
Imatinib—CA12—Brinzolamide—glaucoma	0.0118	0.0248	CbGbCtD
Imatinib—CA14—Acetazolamide—glaucoma	0.0115	0.024	CbGbCtD
Imatinib—CA12—Dorzolamide—glaucoma	0.0114	0.024	CbGbCtD
Imatinib—CA9—Dorzolamide—glaucoma	0.0114	0.024	CbGbCtD
Imatinib—CA1—Diclofenamide—glaucoma	0.0111	0.0232	CbGbCtD
Imatinib—CA1—Brinzolamide—glaucoma	0.0111	0.0232	CbGbCtD
Imatinib—CA6—Acetazolamide—glaucoma	0.0109	0.0228	CbGbCtD
Imatinib—CA1—Dorzolamide—glaucoma	0.0107	0.0224	CbGbCtD
Imatinib—CA12—Methazolamide—glaucoma	0.0102	0.0214	CbGbCtD
Imatinib—CA9—Methazolamide—glaucoma	0.0102	0.0214	CbGbCtD
Imatinib—CA2—Diclofenamide—glaucoma	0.00958	0.0201	CbGbCtD
Imatinib—CA2—Brinzolamide—glaucoma	0.00958	0.0201	CbGbCtD
Imatinib—CA1—Methazolamide—glaucoma	0.00954	0.02	CbGbCtD
Imatinib—CA7—Acetazolamide—glaucoma	0.0095	0.0199	CbGbCtD
Imatinib—CA2—Dorzolamide—glaucoma	0.00925	0.0194	CbGbCtD
Imatinib—SLC22A1—Latanoprost—glaucoma	0.00901	0.0189	CbGbCtD
Imatinib—CA2—Methazolamide—glaucoma	0.00825	0.0173	CbGbCtD
Imatinib—CA9—Acetazolamide—glaucoma	0.00815	0.0171	CbGbCtD
Imatinib—CA12—Acetazolamide—glaucoma	0.00815	0.0171	CbGbCtD
Imatinib—CA1—Acetazolamide—glaucoma	0.00763	0.016	CbGbCtD
Imatinib—CA2—Acetazolamide—glaucoma	0.00659	0.0138	CbGbCtD
Imatinib—SLC22A1—Clonidine—glaucoma	0.00334	0.00698	CbGbCtD
Imatinib—CYP2D6—Carteolol—glaucoma	0.0026	0.00545	CbGbCtD
Imatinib—CYP1A2—Betaxolol—glaucoma	0.00213	0.00447	CbGbCtD
Imatinib—CYP2D6—Betaxolol—glaucoma	0.00176	0.00368	CbGbCtD
Imatinib—CYP2C19—Methazolamide—glaucoma	0.00175	0.00367	CbGbCtD
Imatinib—CYP2C9—Diclofenamide—glaucoma	0.00169	0.00354	CbGbCtD
Imatinib—CYP2C9—Dorzolamide—glaucoma	0.00163	0.00342	CbGbCtD
Imatinib—CYP3A5—Clonidine—glaucoma	0.00157	0.00329	CbGbCtD
Imatinib—CYP2C19—Timolol—glaucoma	0.00149	0.00312	CbGbCtD
Imatinib—CYP2C9—Methazolamide—glaucoma	0.00146	0.00305	CbGbCtD
Imatinib—CYP2D6—Methazolamide—glaucoma	0.00133	0.00279	CbGbCtD
Imatinib—CYP3A4—Pilocarpine—glaucoma	0.00125	0.00262	CbGbCtD
Imatinib—ABCB1—Timolol—glaucoma	0.0012	0.00252	CbGbCtD
Imatinib—CYP1A2—Clonidine—glaucoma	0.00117	0.00245	CbGbCtD
Imatinib—CYP2D6—Timolol—glaucoma	0.00113	0.00237	CbGbCtD
Imatinib—ABCB1—Clonidine—glaucoma	0.00102	0.00214	CbGbCtD
Imatinib—CYP3A4—Brinzolamide—glaucoma	0.000984	0.00206	CbGbCtD
Imatinib—CYP2D6—Clonidine—glaucoma	0.000963	0.00202	CbGbCtD
Imatinib—CYP3A4—Dorzolamide—glaucoma	0.00095	0.00199	CbGbCtD
Imatinib—CYP3A4—Methazolamide—glaucoma	0.000847	0.00177	CbGbCtD
Imatinib—Nilotinib—CA1—glaucoma	0.000792	0.569	CrCbGaD
Imatinib—CYP3A4—Acetazolamide—glaucoma	0.000677	0.00142	CbGbCtD
Imatinib—CYP3A4—Clonidine—glaucoma	0.000612	0.00128	CbGbCtD
Imatinib—Nilotinib—CA2—glaucoma	0.0006	0.431	CrCbGaD
Imatinib—ABCA3—eye—glaucoma	0.00019	0.121	CbGeAlD
Imatinib—KIT—endothelium—glaucoma	0.000129	0.0825	CbGeAlD
Imatinib—PIP4K2C—retina—glaucoma	0.000107	0.0685	CbGeAlD
Imatinib—CA3—connective tissue—glaucoma	9.95e-05	0.0636	CbGeAlD
Imatinib—PDGFRA—connective tissue—glaucoma	7.63e-05	0.0488	CbGeAlD
Imatinib—CA12—eye—glaucoma	7.31e-05	0.0468	CbGeAlD
Imatinib—CA12—connective tissue—glaucoma	7.04e-05	0.045	CbGeAlD
Imatinib—CSF1R—eye—glaucoma	6.97e-05	0.0446	CbGeAlD
Imatinib—CSF1R—connective tissue—glaucoma	6.72e-05	0.043	CbGeAlD
Imatinib—SLC47A1—eye—glaucoma	6.37e-05	0.0407	CbGeAlD
Imatinib—PDGFRB—eye—glaucoma	6.19e-05	0.0396	CbGeAlD
Imatinib—KIT—connective tissue—glaucoma	6.1e-05	0.039	CbGeAlD
Imatinib—PDGFRB—connective tissue—glaucoma	5.96e-05	0.0381	CbGeAlD
Imatinib—PTGS1—endothelium—glaucoma	5.91e-05	0.0378	CbGeAlD
Imatinib—CA1—eye—glaucoma	5.79e-05	0.037	CbGeAlD
Imatinib—ABL1—eye—glaucoma	5.51e-05	0.0353	CbGeAlD
Imatinib—ABL1—retina—glaucoma	5.46e-05	0.0349	CbGeAlD
Imatinib—ABL1—connective tissue—glaucoma	5.31e-05	0.034	CbGeAlD
Imatinib—Conjunctivitis—Timolol—glaucoma	4.2e-05	0.000399	CcSEcCtD
Imatinib—Gastrointestinal pain—Dorzolamide—glaucoma	4.2e-05	0.000399	CcSEcCtD
Imatinib—Alopecia—Betaxolol—glaucoma	4.2e-05	0.000399	CcSEcCtD
Imatinib—Palpitations—Clonidine—glaucoma	4.2e-05	0.000399	CcSEcCtD
Imatinib—Gastrointestinal disorder—Pilocarpine—glaucoma	4.19e-05	0.000398	CcSEcCtD
Imatinib—Gastrointestinal pain—Travoprost—glaucoma	4.18e-05	0.000397	CcSEcCtD
Imatinib—Loss of consciousness—Clonidine—glaucoma	4.17e-05	0.000397	CcSEcCtD
Imatinib—Feeling abnormal—Brinzolamide—glaucoma	4.16e-05	0.000395	CcSEcCtD
Imatinib—Mental disorder—Betaxolol—glaucoma	4.16e-05	0.000395	CcSEcCtD
Imatinib—Pain—Pilocarpine—glaucoma	4.15e-05	0.000394	CcSEcCtD
Imatinib—Constipation—Pilocarpine—glaucoma	4.15e-05	0.000394	CcSEcCtD
Imatinib—Cough—Clonidine—glaucoma	4.14e-05	0.000394	CcSEcCtD
Imatinib—Sweating—Timolol—glaucoma	4.14e-05	0.000394	CcSEcCtD
Imatinib—Dizziness—Apraclonidine—glaucoma	4.14e-05	0.000394	CcSEcCtD
Imatinib—Malnutrition—Betaxolol—glaucoma	4.13e-05	0.000393	CcSEcCtD
Imatinib—Erythema—Betaxolol—glaucoma	4.13e-05	0.000393	CcSEcCtD
Imatinib—Urticaria—Dorzolamide—glaucoma	4.08e-05	0.000388	CcSEcCtD
Imatinib—Epistaxis—Timolol—glaucoma	4.08e-05	0.000387	CcSEcCtD
Imatinib—Abdominal pain—Dorzolamide—glaucoma	4.06e-05	0.000386	CcSEcCtD
Imatinib—Body temperature increased—Dorzolamide—glaucoma	4.06e-05	0.000386	CcSEcCtD
Imatinib—Sinusitis—Timolol—glaucoma	4.06e-05	0.000385	CcSEcCtD
Imatinib—Dysgeusia—Betaxolol—glaucoma	4.05e-05	0.000385	CcSEcCtD
Imatinib—Arthralgia—Clonidine—glaucoma	4.04e-05	0.000384	CcSEcCtD
Imatinib—Chest pain—Clonidine—glaucoma	4.04e-05	0.000384	CcSEcCtD
Imatinib—Abdominal pain—Travoprost—glaucoma	4.04e-05	0.000384	CcSEcCtD
Imatinib—Agranulocytosis—Timolol—glaucoma	4.03e-05	0.000383	CcSEcCtD
Imatinib—Anxiety—Clonidine—glaucoma	4.03e-05	0.000383	CcSEcCtD
Imatinib—Asthenia—Acetazolamide—glaucoma	4.02e-05	0.000382	CcSEcCtD
Imatinib—Dizziness—Bimatoprost—glaucoma	4.02e-05	0.000382	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	4.02e-05	0.000382	CcSEcCtD
Imatinib—Urticaria—Brinzolamide—glaucoma	4.01e-05	0.000381	CcSEcCtD
Imatinib—Feeling abnormal—Pilocarpine—glaucoma	4e-05	0.00038	CcSEcCtD
Imatinib—Discomfort—Clonidine—glaucoma	4e-05	0.00038	CcSEcCtD
Imatinib—Vomiting—Apraclonidine—glaucoma	3.98e-05	0.000378	CcSEcCtD
Imatinib—Muscle spasms—Betaxolol—glaucoma	3.98e-05	0.000378	CcSEcCtD
Imatinib—Gastrointestinal pain—Pilocarpine—glaucoma	3.97e-05	0.000377	CcSEcCtD
Imatinib—Hypersensitivity—Brimonidine—glaucoma	3.96e-05	0.000377	CcSEcCtD
Imatinib—Dry mouth—Clonidine—glaucoma	3.95e-05	0.000376	CcSEcCtD
Imatinib—Dermatitis—Apraclonidine—glaucoma	3.95e-05	0.000375	CcSEcCtD
Imatinib—Headache—Apraclonidine—glaucoma	3.93e-05	0.000373	CcSEcCtD
Imatinib—Confusional state—Clonidine—glaucoma	3.91e-05	0.000371	CcSEcCtD
Imatinib—Vision blurred—Betaxolol—glaucoma	3.9e-05	0.00037	CcSEcCtD
Imatinib—Rhinitis—Timolol—glaucoma	3.89e-05	0.00037	CcSEcCtD
Imatinib—Oedema—Clonidine—glaucoma	3.88e-05	0.000368	CcSEcCtD
Imatinib—Tremor—Betaxolol—glaucoma	3.87e-05	0.000368	CcSEcCtD
Imatinib—Asthenia—Brimonidine—glaucoma	3.86e-05	0.000367	CcSEcCtD
Imatinib—Infection—Clonidine—glaucoma	3.85e-05	0.000366	CcSEcCtD
Imatinib—Body temperature increased—Pilocarpine—glaucoma	3.84e-05	0.000365	CcSEcCtD
Imatinib—Abdominal pain—Pilocarpine—glaucoma	3.84e-05	0.000365	CcSEcCtD
Imatinib—Ill-defined disorder—Betaxolol—glaucoma	3.84e-05	0.000365	CcSEcCtD
Imatinib—Diarrhoea—Acetazolamide—glaucoma	3.83e-05	0.000364	CcSEcCtD
Imatinib—Rash—Bimatoprost—glaucoma	3.83e-05	0.000364	CcSEcCtD
Imatinib—Dermatitis—Bimatoprost—glaucoma	3.83e-05	0.000364	CcSEcCtD
Imatinib—Oedema peripheral—Timolol—glaucoma	3.82e-05	0.000363	CcSEcCtD
Imatinib—Anaemia—Betaxolol—glaucoma	3.82e-05	0.000363	CcSEcCtD
Imatinib—Shock—Clonidine—glaucoma	3.81e-05	0.000362	CcSEcCtD
Imatinib—Connective tissue disorder—Timolol—glaucoma	3.81e-05	0.000362	CcSEcCtD
Imatinib—Pruritus—Brimonidine—glaucoma	3.81e-05	0.000362	CcSEcCtD
Imatinib—Headache—Bimatoprost—glaucoma	3.81e-05	0.000362	CcSEcCtD
Imatinib—Nervous system disorder—Clonidine—glaucoma	3.8e-05	0.000361	CcSEcCtD
Imatinib—Thrombocytopenia—Clonidine—glaucoma	3.8e-05	0.000361	CcSEcCtD
Imatinib—Hypersensitivity—Dorzolamide—glaucoma	3.78e-05	0.00036	CcSEcCtD
Imatinib—Tachycardia—Clonidine—glaucoma	3.78e-05	0.000359	CcSEcCtD
Imatinib—Hypersensitivity—Travoprost—glaucoma	3.77e-05	0.000358	CcSEcCtD
Imatinib—Skin disorder—Clonidine—glaucoma	3.77e-05	0.000358	CcSEcCtD
Imatinib—CA2—eye—glaucoma	3.75e-05	0.024	CbGeAlD
Imatinib—Hyperhidrosis—Clonidine—glaucoma	3.75e-05	0.000356	CcSEcCtD
Imatinib—Malaise—Betaxolol—glaucoma	3.73e-05	0.000354	CcSEcCtD
Imatinib—Nausea—Apraclonidine—glaucoma	3.72e-05	0.000354	CcSEcCtD
Imatinib—Hypersensitivity—Brinzolamide—glaucoma	3.72e-05	0.000354	CcSEcCtD
Imatinib—CA2—retina—glaucoma	3.72e-05	0.0238	CbGeAlD
Imatinib—Vertigo—Betaxolol—glaucoma	3.72e-05	0.000353	CcSEcCtD
Imatinib—Syncope—Betaxolol—glaucoma	3.71e-05	0.000352	CcSEcCtD
Imatinib—Dizziness—Acetazolamide—glaucoma	3.71e-05	0.000352	CcSEcCtD
Imatinib—Anorexia—Clonidine—glaucoma	3.69e-05	0.000351	CcSEcCtD
Imatinib—Asthenia—Dorzolamide—glaucoma	3.69e-05	0.00035	CcSEcCtD
Imatinib—Asthenia—Travoprost—glaucoma	3.67e-05	0.000349	CcSEcCtD
Imatinib—Palpitations—Betaxolol—glaucoma	3.65e-05	0.000347	CcSEcCtD
Imatinib—Pruritus—Dorzolamide—glaucoma	3.63e-05	0.000345	CcSEcCtD
Imatinib—Loss of consciousness—Betaxolol—glaucoma	3.63e-05	0.000345	CcSEcCtD
Imatinib—Eye disorder—Timolol—glaucoma	3.63e-05	0.000345	CcSEcCtD
Imatinib—Asthenia—Brinzolamide—glaucoma	3.62e-05	0.000344	CcSEcCtD
Imatinib—Hypotension—Clonidine—glaucoma	3.62e-05	0.000344	CcSEcCtD
Imatinib—Pruritus—Travoprost—glaucoma	3.62e-05	0.000344	CcSEcCtD
Imatinib—Tinnitus—Timolol—glaucoma	3.62e-05	0.000344	CcSEcCtD
Imatinib—CA2—connective tissue—glaucoma	3.62e-05	0.0231	CbGeAlD
Imatinib—Cough—Betaxolol—glaucoma	3.61e-05	0.000343	CcSEcCtD
Imatinib—Nausea—Bimatoprost—glaucoma	3.61e-05	0.000343	CcSEcCtD
Imatinib—Cardiac disorder—Timolol—glaucoma	3.6e-05	0.000342	CcSEcCtD
Imatinib—Hypersensitivity—Pilocarpine—glaucoma	3.58e-05	0.00034	CcSEcCtD
Imatinib—Pruritus—Brinzolamide—glaucoma	3.57e-05	0.000339	CcSEcCtD
Imatinib—Vomiting—Acetazolamide—glaucoma	3.56e-05	0.000339	CcSEcCtD
Imatinib—Dizziness—Brimonidine—glaucoma	3.56e-05	0.000338	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Clonidine—glaucoma	3.53e-05	0.000336	CcSEcCtD
Imatinib—Angiopathy—Timolol—glaucoma	3.52e-05	0.000335	CcSEcCtD
Imatinib—Chest pain—Betaxolol—glaucoma	3.52e-05	0.000334	CcSEcCtD
Imatinib—Arthralgia—Betaxolol—glaucoma	3.52e-05	0.000334	CcSEcCtD
Imatinib—Myalgia—Betaxolol—glaucoma	3.52e-05	0.000334	CcSEcCtD
Imatinib—Diarrhoea—Dorzolamide—glaucoma	3.51e-05	0.000334	CcSEcCtD
Imatinib—Headache—Acetazolamide—glaucoma	3.51e-05	0.000334	CcSEcCtD
Imatinib—Anxiety—Betaxolol—glaucoma	3.51e-05	0.000333	CcSEcCtD
Imatinib—Insomnia—Clonidine—glaucoma	3.51e-05	0.000333	CcSEcCtD
Imatinib—Immune system disorder—Timolol—glaucoma	3.51e-05	0.000333	CcSEcCtD
Imatinib—Diarrhoea—Travoprost—glaucoma	3.5e-05	0.000333	CcSEcCtD
Imatinib—Mediastinal disorder—Timolol—glaucoma	3.5e-05	0.000332	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	3.5e-05	0.000332	CcSEcCtD
Imatinib—Asthenia—Pilocarpine—glaucoma	3.48e-05	0.000331	CcSEcCtD
Imatinib—Paraesthesia—Clonidine—glaucoma	3.48e-05	0.000331	CcSEcCtD
Imatinib—Discomfort—Betaxolol—glaucoma	3.48e-05	0.00033	CcSEcCtD
Imatinib—Arrhythmia—Timolol—glaucoma	3.47e-05	0.000329	CcSEcCtD
Imatinib—Dyspnoea—Clonidine—glaucoma	3.46e-05	0.000328	CcSEcCtD
Imatinib—Diarrhoea—Brinzolamide—glaucoma	3.46e-05	0.000328	CcSEcCtD
Imatinib—Somnolence—Clonidine—glaucoma	3.45e-05	0.000327	CcSEcCtD
Imatinib—Dry mouth—Betaxolol—glaucoma	3.44e-05	0.000327	CcSEcCtD
Imatinib—Pruritus—Pilocarpine—glaucoma	3.43e-05	0.000326	CcSEcCtD
Imatinib—Alopecia—Timolol—glaucoma	3.43e-05	0.000326	CcSEcCtD
Imatinib—Confusional state—Betaxolol—glaucoma	3.4e-05	0.000323	CcSEcCtD
Imatinib—Mental disorder—Timolol—glaucoma	3.4e-05	0.000323	CcSEcCtD
Imatinib—Dizziness—Dorzolamide—glaucoma	3.4e-05	0.000323	CcSEcCtD
Imatinib—Rash—Brimonidine—glaucoma	3.39e-05	0.000322	CcSEcCtD
Imatinib—Dermatitis—Brimonidine—glaucoma	3.39e-05	0.000322	CcSEcCtD
Imatinib—Dizziness—Travoprost—glaucoma	3.38e-05	0.000321	CcSEcCtD
Imatinib—Erythema—Timolol—glaucoma	3.38e-05	0.000321	CcSEcCtD
Imatinib—Malnutrition—Timolol—glaucoma	3.38e-05	0.000321	CcSEcCtD
Imatinib—Oedema—Betaxolol—glaucoma	3.37e-05	0.000321	CcSEcCtD
Imatinib—Headache—Brimonidine—glaucoma	3.37e-05	0.00032	CcSEcCtD
Imatinib—Decreased appetite—Clonidine—glaucoma	3.37e-05	0.00032	CcSEcCtD
Imatinib—Infection—Betaxolol—glaucoma	3.35e-05	0.000319	CcSEcCtD
Imatinib—Gastrointestinal disorder—Clonidine—glaucoma	3.35e-05	0.000318	CcSEcCtD
Imatinib—Fatigue—Clonidine—glaucoma	3.34e-05	0.000318	CcSEcCtD
Imatinib—Dizziness—Brinzolamide—glaucoma	3.34e-05	0.000317	CcSEcCtD
Imatinib—Nausea—Acetazolamide—glaucoma	3.33e-05	0.000316	CcSEcCtD
Imatinib—Diarrhoea—Pilocarpine—glaucoma	3.32e-05	0.000316	CcSEcCtD
Imatinib—Shock—Betaxolol—glaucoma	3.32e-05	0.000315	CcSEcCtD
Imatinib—Pain—Clonidine—glaucoma	3.31e-05	0.000315	CcSEcCtD
Imatinib—Constipation—Clonidine—glaucoma	3.31e-05	0.000315	CcSEcCtD
Imatinib—Nervous system disorder—Betaxolol—glaucoma	3.31e-05	0.000314	CcSEcCtD
Imatinib—Dysgeusia—Timolol—glaucoma	3.31e-05	0.000314	CcSEcCtD
Imatinib—Thrombocytopenia—Betaxolol—glaucoma	3.3e-05	0.000314	CcSEcCtD
Imatinib—Tachycardia—Betaxolol—glaucoma	3.29e-05	0.000313	CcSEcCtD
Imatinib—Skin disorder—Betaxolol—glaucoma	3.28e-05	0.000311	CcSEcCtD
Imatinib—Vomiting—Dorzolamide—glaucoma	3.27e-05	0.00031	CcSEcCtD
Imatinib—Hyperhidrosis—Betaxolol—glaucoma	3.26e-05	0.00031	CcSEcCtD
Imatinib—Rash—Dorzolamide—glaucoma	3.24e-05	0.000308	CcSEcCtD
Imatinib—Dermatitis—Dorzolamide—glaucoma	3.24e-05	0.000307	CcSEcCtD
Imatinib—Rash—Travoprost—glaucoma	3.22e-05	0.000306	CcSEcCtD
Imatinib—Dermatitis—Travoprost—glaucoma	3.22e-05	0.000306	CcSEcCtD
Imatinib—Headache—Dorzolamide—glaucoma	3.22e-05	0.000306	CcSEcCtD
Imatinib—Anorexia—Betaxolol—glaucoma	3.22e-05	0.000306	CcSEcCtD
Imatinib—Vomiting—Brinzolamide—glaucoma	3.21e-05	0.000305	CcSEcCtD
Imatinib—Dizziness—Pilocarpine—glaucoma	3.21e-05	0.000305	CcSEcCtD
Imatinib—Headache—Travoprost—glaucoma	3.2e-05	0.000304	CcSEcCtD
Imatinib—Nausea—Brimonidine—glaucoma	3.2e-05	0.000304	CcSEcCtD
Imatinib—Feeling abnormal—Clonidine—glaucoma	3.19e-05	0.000304	CcSEcCtD
Imatinib—Rash—Brinzolamide—glaucoma	3.18e-05	0.000303	CcSEcCtD
Imatinib—Vision blurred—Timolol—glaucoma	3.18e-05	0.000302	CcSEcCtD
Imatinib—Dermatitis—Brinzolamide—glaucoma	3.18e-05	0.000302	CcSEcCtD
Imatinib—Gastrointestinal pain—Clonidine—glaucoma	3.17e-05	0.000301	CcSEcCtD
Imatinib—Headache—Brinzolamide—glaucoma	3.16e-05	0.000301	CcSEcCtD
Imatinib—Hypotension—Betaxolol—glaucoma	3.15e-05	0.0003	CcSEcCtD
Imatinib—Angioedema—Timolol—glaucoma	3.09e-05	0.000293	CcSEcCtD
Imatinib—Vomiting—Pilocarpine—glaucoma	3.09e-05	0.000293	CcSEcCtD
Imatinib—Urticaria—Clonidine—glaucoma	3.08e-05	0.000293	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Betaxolol—glaucoma	3.07e-05	0.000292	CcSEcCtD
Imatinib—Body temperature increased—Clonidine—glaucoma	3.06e-05	0.000291	CcSEcCtD
Imatinib—Abdominal pain—Clonidine—glaucoma	3.06e-05	0.000291	CcSEcCtD
Imatinib—Rash—Pilocarpine—glaucoma	3.06e-05	0.000291	CcSEcCtD
Imatinib—Dermatitis—Pilocarpine—glaucoma	3.06e-05	0.000291	CcSEcCtD
Imatinib—Insomnia—Betaxolol—glaucoma	3.05e-05	0.00029	CcSEcCtD
Imatinib—Nausea—Dorzolamide—glaucoma	3.05e-05	0.00029	CcSEcCtD
Imatinib—Headache—Pilocarpine—glaucoma	3.04e-05	0.000289	CcSEcCtD
Imatinib—Nausea—Travoprost—glaucoma	3.04e-05	0.000289	CcSEcCtD
Imatinib—Vertigo—Timolol—glaucoma	3.03e-05	0.000288	CcSEcCtD
Imatinib—Paraesthesia—Betaxolol—glaucoma	3.03e-05	0.000288	CcSEcCtD
Imatinib—Syncope—Timolol—glaucoma	3.03e-05	0.000288	CcSEcCtD
Imatinib—Dyspnoea—Betaxolol—glaucoma	3.01e-05	0.000286	CcSEcCtD
Imatinib—Nausea—Brinzolamide—glaucoma	3e-05	0.000285	CcSEcCtD
Imatinib—Palpitations—Timolol—glaucoma	2.99e-05	0.000284	CcSEcCtD
Imatinib—Dyspepsia—Betaxolol—glaucoma	2.97e-05	0.000282	CcSEcCtD
Imatinib—Loss of consciousness—Timolol—glaucoma	2.97e-05	0.000282	CcSEcCtD
Imatinib—Cough—Timolol—glaucoma	2.95e-05	0.00028	CcSEcCtD
Imatinib—Decreased appetite—Betaxolol—glaucoma	2.93e-05	0.000279	CcSEcCtD
Imatinib—Hypertension—Timolol—glaucoma	2.92e-05	0.000277	CcSEcCtD
Imatinib—Gastrointestinal disorder—Betaxolol—glaucoma	2.91e-05	0.000277	CcSEcCtD
Imatinib—Fatigue—Betaxolol—glaucoma	2.91e-05	0.000276	CcSEcCtD
Imatinib—Pain—Betaxolol—glaucoma	2.89e-05	0.000274	CcSEcCtD
Imatinib—Constipation—Betaxolol—glaucoma	2.89e-05	0.000274	CcSEcCtD
Imatinib—Nausea—Pilocarpine—glaucoma	2.88e-05	0.000274	CcSEcCtD
Imatinib—Myalgia—Timolol—glaucoma	2.88e-05	0.000273	CcSEcCtD
Imatinib—Chest pain—Timolol—glaucoma	2.88e-05	0.000273	CcSEcCtD
Imatinib—Arthralgia—Timolol—glaucoma	2.88e-05	0.000273	CcSEcCtD
Imatinib—Anxiety—Timolol—glaucoma	2.87e-05	0.000272	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	2.86e-05	0.000271	CcSEcCtD
Imatinib—Hypersensitivity—Clonidine—glaucoma	2.86e-05	0.000271	CcSEcCtD
Imatinib—Discomfort—Timolol—glaucoma	2.84e-05	0.00027	CcSEcCtD
Imatinib—Dry mouth—Timolol—glaucoma	2.81e-05	0.000267	CcSEcCtD
Imatinib—PTGS1—connective tissue—glaucoma	2.79e-05	0.0179	CbGeAlD
Imatinib—Asthenia—Clonidine—glaucoma	2.78e-05	0.000264	CcSEcCtD
Imatinib—Feeling abnormal—Betaxolol—glaucoma	2.78e-05	0.000264	CcSEcCtD
Imatinib—Confusional state—Timolol—glaucoma	2.78e-05	0.000264	CcSEcCtD
Imatinib—Oedema—Timolol—glaucoma	2.76e-05	0.000262	CcSEcCtD
Imatinib—Anaphylactic shock—Timolol—glaucoma	2.76e-05	0.000262	CcSEcCtD
Imatinib—Pruritus—Clonidine—glaucoma	2.74e-05	0.000261	CcSEcCtD
Imatinib—Infection—Timolol—glaucoma	2.74e-05	0.00026	CcSEcCtD
Imatinib—Shock—Timolol—glaucoma	2.71e-05	0.000258	CcSEcCtD
Imatinib—Nervous system disorder—Timolol—glaucoma	2.7e-05	0.000257	CcSEcCtD
Imatinib—Urticaria—Betaxolol—glaucoma	2.68e-05	0.000255	CcSEcCtD
Imatinib—Skin disorder—Timolol—glaucoma	2.68e-05	0.000254	CcSEcCtD
Imatinib—Body temperature increased—Betaxolol—glaucoma	2.67e-05	0.000253	CcSEcCtD
Imatinib—Hyperhidrosis—Timolol—glaucoma	2.67e-05	0.000253	CcSEcCtD
Imatinib—Diarrhoea—Clonidine—glaucoma	2.65e-05	0.000252	CcSEcCtD
Imatinib—Anorexia—Timolol—glaucoma	2.63e-05	0.00025	CcSEcCtD
Imatinib—Hypotension—Timolol—glaucoma	2.58e-05	0.000245	CcSEcCtD
Imatinib—Dizziness—Clonidine—glaucoma	2.56e-05	0.000244	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Timolol—glaucoma	2.51e-05	0.000239	CcSEcCtD
Imatinib—Insomnia—Timolol—glaucoma	2.49e-05	0.000237	CcSEcCtD
Imatinib—Hypersensitivity—Betaxolol—glaucoma	2.49e-05	0.000236	CcSEcCtD
Imatinib—Paraesthesia—Timolol—glaucoma	2.48e-05	0.000235	CcSEcCtD
Imatinib—Vomiting—Clonidine—glaucoma	2.46e-05	0.000234	CcSEcCtD
Imatinib—Dyspnoea—Timolol—glaucoma	2.46e-05	0.000234	CcSEcCtD
Imatinib—Somnolence—Timolol—glaucoma	2.45e-05	0.000233	CcSEcCtD
Imatinib—Rash—Clonidine—glaucoma	2.44e-05	0.000232	CcSEcCtD
Imatinib—Dermatitis—Clonidine—glaucoma	2.44e-05	0.000232	CcSEcCtD
Imatinib—Headache—Clonidine—glaucoma	2.43e-05	0.000231	CcSEcCtD
Imatinib—Dyspepsia—Timolol—glaucoma	2.43e-05	0.000231	CcSEcCtD
Imatinib—Asthenia—Betaxolol—glaucoma	2.42e-05	0.00023	CcSEcCtD
Imatinib—Decreased appetite—Timolol—glaucoma	2.4e-05	0.000228	CcSEcCtD
Imatinib—Pruritus—Betaxolol—glaucoma	2.39e-05	0.000227	CcSEcCtD
Imatinib—Gastrointestinal disorder—Timolol—glaucoma	2.38e-05	0.000226	CcSEcCtD
Imatinib—Fatigue—Timolol—glaucoma	2.38e-05	0.000226	CcSEcCtD
Imatinib—Pain—Timolol—glaucoma	2.36e-05	0.000224	CcSEcCtD
Imatinib—Diarrhoea—Betaxolol—glaucoma	2.31e-05	0.000219	CcSEcCtD
Imatinib—Nausea—Clonidine—glaucoma	2.3e-05	0.000219	CcSEcCtD
Imatinib—Feeling abnormal—Timolol—glaucoma	2.27e-05	0.000216	CcSEcCtD
Imatinib—Gastrointestinal pain—Timolol—glaucoma	2.25e-05	0.000214	CcSEcCtD
Imatinib—Dizziness—Betaxolol—glaucoma	2.23e-05	0.000212	CcSEcCtD
Imatinib—Urticaria—Timolol—glaucoma	2.19e-05	0.000208	CcSEcCtD
Imatinib—Abdominal pain—Timolol—glaucoma	2.18e-05	0.000207	CcSEcCtD
Imatinib—Body temperature increased—Timolol—glaucoma	2.18e-05	0.000207	CcSEcCtD
Imatinib—Vomiting—Betaxolol—glaucoma	2.15e-05	0.000204	CcSEcCtD
Imatinib—Rash—Betaxolol—glaucoma	2.13e-05	0.000202	CcSEcCtD
Imatinib—Dermatitis—Betaxolol—glaucoma	2.13e-05	0.000202	CcSEcCtD
Imatinib—Headache—Betaxolol—glaucoma	2.11e-05	0.000201	CcSEcCtD
Imatinib—Hypersensitivity—Timolol—glaucoma	2.03e-05	0.000193	CcSEcCtD
Imatinib—Nausea—Betaxolol—glaucoma	2e-05	0.00019	CcSEcCtD
Imatinib—Asthenia—Timolol—glaucoma	1.98e-05	0.000188	CcSEcCtD
Imatinib—Pruritus—Timolol—glaucoma	1.95e-05	0.000185	CcSEcCtD
Imatinib—Diarrhoea—Timolol—glaucoma	1.89e-05	0.000179	CcSEcCtD
Imatinib—Dizziness—Timolol—glaucoma	1.82e-05	0.000173	CcSEcCtD
Imatinib—Vomiting—Timolol—glaucoma	1.75e-05	0.000167	CcSEcCtD
Imatinib—Rash—Timolol—glaucoma	1.74e-05	0.000165	CcSEcCtD
Imatinib—Dermatitis—Timolol—glaucoma	1.74e-05	0.000165	CcSEcCtD
Imatinib—Headache—Timolol—glaucoma	1.73e-05	0.000164	CcSEcCtD
Imatinib—ABCB1—retina—glaucoma	1.7e-05	0.0109	CbGeAlD
Imatinib—Nausea—Timolol—glaucoma	1.64e-05	0.000156	CcSEcCtD
Imatinib—CYP1A2—Metabolism—CTSA—glaucoma	2.9e-06	3.63e-05	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	2.89e-06	3.63e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—BAD—glaucoma	2.88e-06	3.61e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CDKN2B—glaucoma	2.86e-06	3.59e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NGFR—glaucoma	2.85e-06	3.58e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—MMP1—glaucoma	2.85e-06	3.58e-05	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.85e-06	3.57e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—EDN1—glaucoma	2.81e-06	3.53e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—BAD—glaucoma	2.81e-06	3.53e-05	CbGpPWpGaD
Imatinib—CA1—Metabolism—PTGS2—glaucoma	2.8e-06	3.51e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—APOE—glaucoma	2.79e-06	3.49e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CDKN2B—glaucoma	2.77e-06	3.48e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CAV1—glaucoma	2.76e-06	3.46e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ABCA1—glaucoma	2.76e-06	3.46e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CYP1B1—glaucoma	2.76e-06	3.46e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—TXN—glaucoma	2.75e-06	3.45e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—BAD—glaucoma	2.74e-06	3.44e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—CAV1—glaucoma	2.73e-06	3.43e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CA2—glaucoma	2.73e-06	3.43e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CYP1B1—glaucoma	2.73e-06	3.43e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ABCA1—glaucoma	2.73e-06	3.43e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ABCA1—glaucoma	2.73e-06	3.42e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CYP1B1—glaucoma	2.73e-06	3.42e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NTRK1—glaucoma	2.71e-06	3.4e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CDKN1B—glaucoma	2.7e-06	3.38e-05	CbGpPWpGaD
Imatinib—CA9—Metabolism—NOS3—glaucoma	2.69e-06	3.37e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.68e-06	3.36e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.67e-06	3.35e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.67e-06	3.35e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NTRK2—glaucoma	2.67e-06	3.35e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—EDN1—glaucoma	2.66e-06	3.34e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CYP1B1—glaucoma	2.65e-06	3.32e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ABCA1—glaucoma	2.65e-06	3.32e-05	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—TNF—glaucoma	2.64e-06	3.32e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—FN1—glaucoma	2.6e-06	3.27e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—C3—glaucoma	2.6e-06	3.26e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—BAD—glaucoma	2.6e-06	3.26e-05	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CDKN1B—glaucoma	2.59e-06	3.25e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NGF—glaucoma	2.58e-06	3.24e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ABCA1—glaucoma	2.54e-06	3.19e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CYP1B1—glaucoma	2.54e-06	3.19e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.51e-06	3.15e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CDKN2B—glaucoma	2.5e-06	3.14e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—VEGFA—glaucoma	2.49e-06	3.13e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.49e-06	3.12e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—BCL2L1—glaucoma	2.49e-06	3.12e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GSTT1—glaucoma	2.48e-06	3.11e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—TXN—glaucoma	2.47e-06	3.1e-05	CbGpPWpGaD
Imatinib—CA9—Metabolism—PTGS2—glaucoma	2.46e-06	3.08e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—C3—glaucoma	2.46e-06	3.08e-05	CbGpPWpGaD
Imatinib—KIT—Disease—NOS3—glaucoma	2.45e-06	3.07e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NGF—glaucoma	2.45e-06	3.07e-05	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.44e-06	3.06e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—TXN—glaucoma	2.41e-06	3.03e-05	CbGpPWpGaD
Imatinib—LCK—Disease—MTHFR—glaucoma	2.4e-06	3.01e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—EDN1—glaucoma	2.4e-06	3.01e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NOS3—glaucoma	2.34e-06	2.93e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—C3—glaucoma	2.33e-06	2.92e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NOS3—glaucoma	2.32e-06	2.91e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CA1—glaucoma	2.31e-06	2.89e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—CDKN1B—glaucoma	2.3e-06	2.88e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NGFR—glaucoma	2.29e-06	2.87e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—APOE—glaucoma	2.29e-06	2.87e-05	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TP53—glaucoma	2.29e-06	2.87e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—TXN—glaucoma	2.27e-06	2.85e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CAV1—glaucoma	2.27e-06	2.84e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—BAD—glaucoma	2.26e-06	2.83e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.26e-06	2.83e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—TXN—glaucoma	2.25e-06	2.83e-05	CbGpPWpGaD
Imatinib—KIT—Disease—PTGS2—glaucoma	2.24e-06	2.81e-05	CbGpPWpGaD
Imatinib—LCK—Disease—APOE—glaucoma	2.24e-06	2.8e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.24e-06	2.8e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CTSA—glaucoma	2.23e-06	2.8e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CAV1—glaucoma	2.21e-06	2.78e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GSTM1—glaucoma	2.2e-06	2.77e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NGF—glaucoma	2.2e-06	2.76e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GSTM1—glaucoma	2.18e-06	2.74e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GSTM1—glaucoma	2.18e-06	2.74e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NTRK1—glaucoma	2.18e-06	2.73e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CDKN1B—glaucoma	2.17e-06	2.73e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—APOE—glaucoma	2.17e-06	2.72e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FN1—glaucoma	2.16e-06	2.71e-05	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.15e-06	2.7e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CAV1—glaucoma	2.15e-06	2.69e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GSTT1—glaucoma	2.14e-06	2.68e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—BAD—glaucoma	2.13e-06	2.67e-05	CbGpPWpGaD
Imatinib—KIT—Disease—CDKN1B—glaucoma	2.12e-06	2.66e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—PTGS2—glaucoma	2.12e-06	2.66e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GSTM1—glaucoma	2.12e-06	2.66e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CA2—glaucoma	2.11e-06	2.65e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—C3—glaucoma	2.1e-06	2.63e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NOS3—glaucoma	2.09e-06	2.62e-05	CbGpPWpGaD
Imatinib—LCK—Disease—BAD—glaucoma	2.08e-06	2.61e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—NOS3—glaucoma	2.07e-06	2.59e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.06e-06	2.58e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FN1—glaucoma	2.04e-06	2.56e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.04e-06	2.56e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GSTM1—glaucoma	2.03e-06	2.55e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CDKN1B—glaucoma	2.03e-06	2.54e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—BAD—glaucoma	2.02e-06	2.53e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CDKN1B—glaucoma	2.01e-06	2.52e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CDKN2B—glaucoma	2.01e-06	2.52e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ABCA1—glaucoma	1.98e-06	2.48e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CYP1B1—glaucoma	1.98e-06	2.48e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CDKN1B—glaucoma	1.96e-06	2.46e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—APOE—glaucoma	1.95e-06	2.45e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MTHFR—glaucoma	1.95e-06	2.44e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CAV1—glaucoma	1.93e-06	2.42e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MTHFR—glaucoma	1.93e-06	2.42e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MTHFR—glaucoma	1.93e-06	2.42e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—TXN—glaucoma	1.93e-06	2.42e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—EDN1—glaucoma	1.92e-06	2.41e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GSTT1—glaucoma	1.92e-06	2.4e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PTGS2—glaucoma	1.91e-06	2.39e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CDKN1B—glaucoma	1.91e-06	2.39e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—glaucoma	1.88e-06	2.36e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MMP9—glaucoma	1.88e-06	2.35e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MTHFR—glaucoma	1.87e-06	2.35e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GSTT1—glaucoma	1.87e-06	2.35e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FN1—glaucoma	1.84e-06	2.31e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—BAD—glaucoma	1.82e-06	2.28e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—APOE—glaucoma	1.81e-06	2.28e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CDKN1B—glaucoma	1.81e-06	2.27e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—APOE—glaucoma	1.8e-06	2.26e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MTHFR—glaucoma	1.8e-06	2.25e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CAV1—glaucoma	1.8e-06	2.25e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—APOE—glaucoma	1.79e-06	2.25e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CAV1—glaucoma	1.78e-06	2.23e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CAV1—glaucoma	1.78e-06	2.23e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NGF—glaucoma	1.77e-06	2.22e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GSTT1—glaucoma	1.76e-06	2.21e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.76e-06	2.2e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GSTT1—glaucoma	1.75e-06	2.19e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—APOE—glaucoma	1.74e-06	2.19e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.74e-06	2.18e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CAV1—glaucoma	1.73e-06	2.17e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.72e-06	2.16e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NOS3—glaucoma	1.71e-06	2.15e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—ABCA1—glaucoma	1.7e-06	2.13e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CYP1B1—glaucoma	1.7e-06	2.13e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—VEGFA—glaucoma	1.68e-06	2.11e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—C3—glaucoma	1.68e-06	2.11e-05	CbGpPWpGaD
Imatinib—LCK—Disease—NOS3—glaucoma	1.67e-06	2.1e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—APOE—glaucoma	1.67e-06	2.1e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CAV1—glaucoma	1.66e-06	2.08e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NOS3—glaucoma	1.62e-06	2.03e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GSTM1—glaucoma	1.58e-06	1.98e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CDKN1B—glaucoma	1.57e-06	1.97e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—APOE—glaucoma	1.57e-06	1.96e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CAV1—glaucoma	1.55e-06	1.95e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.55e-06	1.94e-05	CbGpPWpGaD
Imatinib—LCK—Disease—PTGS2—glaucoma	1.53e-06	1.92e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CYP1B1—glaucoma	1.53e-06	1.92e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ABCA1—glaucoma	1.53e-06	1.92e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GSTT1—glaucoma	1.49e-06	1.87e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ABCA1—glaucoma	1.49e-06	1.87e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CYP1B1—glaucoma	1.49e-06	1.87e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—VEGFA—glaucoma	1.49e-06	1.87e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TXN—glaucoma	1.49e-06	1.86e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CDKN1B—glaucoma	1.48e-06	1.86e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FN1—glaucoma	1.48e-06	1.85e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NOS3—glaucoma	1.46e-06	1.83e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—BAD—glaucoma	1.46e-06	1.83e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CDKN1B—glaucoma	1.45e-06	1.82e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.41e-06	1.77e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CDKN1B—glaucoma	1.41e-06	1.76e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ABCA1—glaucoma	1.4e-06	1.76e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CYP1B1—glaucoma	1.4e-06	1.76e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MTHFR—glaucoma	1.4e-06	1.75e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CYP1B1—glaucoma	1.39e-06	1.75e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ABCA1—glaucoma	1.39e-06	1.75e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MMP9—glaucoma	1.37e-06	1.72e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GSTM1—glaucoma	1.36e-06	1.71e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—NOS3—glaucoma	1.36e-06	1.7e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—NOS3—glaucoma	1.35e-06	1.69e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—NOS3—glaucoma	1.34e-06	1.69e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—NOS3—glaucoma	1.31e-06	1.64e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MMP9—glaucoma	1.3e-06	1.63e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—APOE—glaucoma	1.3e-06	1.63e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CAV1—glaucoma	1.29e-06	1.62e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—glaucoma	1.27e-06	1.6e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CDKN1B—glaucoma	1.27e-06	1.59e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—NOS3—glaucoma	1.25e-06	1.57e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTGS2—glaucoma	1.24e-06	1.56e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—VEGFA—glaucoma	1.23e-06	1.55e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTGS2—glaucoma	1.23e-06	1.55e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTGS2—glaucoma	1.23e-06	1.54e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GSTM1—glaucoma	1.22e-06	1.53e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.2e-06	1.51e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—MTHFR—glaucoma	1.2e-06	1.51e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTGS2—glaucoma	1.19e-06	1.5e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GSTM1—glaucoma	1.19e-06	1.49e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CYP1B1—glaucoma	1.19e-06	1.49e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ABCA1—glaucoma	1.19e-06	1.49e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NOS3—glaucoma	1.17e-06	1.47e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MMP9—glaucoma	1.17e-06	1.47e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—VEGFA—glaucoma	1.17e-06	1.47e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GSTT1—glaucoma	1.15e-06	1.45e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTGS2—glaucoma	1.15e-06	1.44e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—glaucoma	1.13e-06	1.41e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GSTM1—glaucoma	1.12e-06	1.41e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOE—glaucoma	1.12e-06	1.4e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GSTM1—glaucoma	1.11e-06	1.4e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CAV1—glaucoma	1.11e-06	1.39e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MTHFR—glaucoma	1.08e-06	1.35e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MTHFR—glaucoma	1.05e-06	1.32e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—VEGFA—glaucoma	1.05e-06	1.32e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CDKN1B—glaucoma	1.02e-06	1.27e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOE—glaucoma	1e-06	1.26e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CAV1—glaucoma	9.95e-07	1.25e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MTHFR—glaucoma	9.93e-07	1.25e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MTHFR—glaucoma	9.84e-07	1.23e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOE—glaucoma	9.81e-07	1.23e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NOS3—glaucoma	9.74e-07	1.22e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CAV1—glaucoma	9.72e-07	1.22e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GSTM1—glaucoma	9.51e-07	1.19e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MMP9—glaucoma	9.41e-07	1.18e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—glaucoma	9.33e-07	1.17e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOE—glaucoma	9.24e-07	1.16e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ABCA1—glaucoma	9.18e-07	1.15e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP1B1—glaucoma	9.18e-07	1.15e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOE—glaucoma	9.16e-07	1.15e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CAV1—glaucoma	9.16e-07	1.15e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CAV1—glaucoma	9.08e-07	1.14e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGS2—glaucoma	8.9e-07	1.12e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—glaucoma	8.83e-07	1.11e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—VEGFA—glaucoma	8.45e-07	1.06e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MTHFR—glaucoma	8.41e-07	1.05e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—NOS3—glaucoma	8.38e-07	1.05e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—glaucoma	7.96e-07	9.98e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOE—glaucoma	7.83e-07	9.82e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CAV1—glaucoma	7.76e-07	9.73e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGS2—glaucoma	7.67e-07	9.62e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NOS3—glaucoma	7.53e-07	9.44e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NOS3—glaucoma	7.35e-07	9.21e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GSTM1—glaucoma	7.34e-07	9.21e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NOS3—glaucoma	6.92e-07	8.68e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGS2—glaucoma	6.88e-07	8.63e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NOS3—glaucoma	6.86e-07	8.61e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGS2—glaucoma	6.72e-07	8.43e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MTHFR—glaucoma	6.49e-07	8.14e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—glaucoma	6.38e-07	8.01e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGS2—glaucoma	6.33e-07	7.94e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGS2—glaucoma	6.28e-07	7.87e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOE—glaucoma	6.04e-07	7.58e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CAV1—glaucoma	5.99e-07	7.51e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NOS3—glaucoma	5.86e-07	7.36e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGS2—glaucoma	5.36e-07	6.73e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NOS3—glaucoma	4.53e-07	5.68e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGS2—glaucoma	4.14e-07	5.19e-06	CbGpPWpGaD
